Skip to main content
. 2018 Dec 18;316(2):E186–E195. doi: 10.1152/ajpendo.00258.2018

Table 2.

Fasting biochemical measurements

T2D, n = 27 Obese Control, n = 21 P Value
HbA1c, % 7.3 (6.2, 10.1) 5.4 (5.2, 5.5) <0.001
Leptin, ng/ml 27.6 (20.2, 40.8) 34.8 (27.1, 49.0) 0.09
Adiponectin, ng/ml 4.5 (3.5, 8.3) 7.9 (6.0, 10.4) 0.01
Cholesterol, ng/ml 140 (131, 183) 157 (127, 184) 0.45
HDL, mg/dl 34 (31, 39) 38 (32, 45) 0.18
LDL, mg/dl 79 ± 26 95 ± 31 0.03
Triglyceride, mg/dl 108 (77, 231) 100 (87, 165) 0.95
C-peptide, ng/ml 2.5 (0.9, 3.9) 2.8 (2.0, 3.5) 0.47
AST, U/l 30 (19, 41) 37 (30, 52) 0.04
ALT, U/l 24 (16, 62) 32 (24, 36) 0.47
WBC, 109cells/l 7.9 (6.4, 9.8) 6.8 (5.3, 7.9) 0.05
Platelets, 109 cells/l 283 (253, 333) 259 (243, 295) 0.07
hs-CRP, mg/l 3.3 (1.0, 5.9) 1.1 (0.4, 2.3) 0.03

Laboratory measures drawn at 6 AM after a 12-h monitored inpatient fast. Data are presented as median and interquartile range (25%, 75%) or as mean ± standard deviation. Bolded values indicate P value of <0.05. ALT, alanine aminotransferase; AST, aspartate aminotransferase; hs-CRP, highly selective C-reactive protein; T2D, type 2 diabetes.